A modelled comparison of prostate cancer control rates after high-dose-rate brachytherapy (3145 multicentre patients) combined with, or in contrast to, external-beam radiotherapy.
Affiliation
Centre for Biostatistics, Institute of Population Health, Manchester Academic Health Sciences Centre, University of Manchester, United Kingdom.Issue Date
2014-02-20
Metadata
Show full item recordAbstract
To analyse biochemical relapse-free-survival results for prostate cancer patients receiving combined external beam and high-dose-rate brachytherapy, in comparison with expected results using projections based on dose/fractionation/response parameter values deduced from a previous external-beam-alone 5969-patient multicentre dataset.Citation
A modelled comparison of prostate cancer control rates after high-dose-rate brachytherapy (3145 multicentre patients) combined with, or in contrast to, external-beam radiotherapy. 2014: Radiother OncolJournal
Radiotherapy and OncologyDOI
10.1016/j.radonc.2014.01.008PubMed ID
24560762Type
ArticleLanguage
enISSN
1879-0887ae974a485f413a2113503eed53cd6c53
10.1016/j.radonc.2014.01.008
Scopus Count
Collections
Related articles
- Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
- Authors: Akimoto T, Ito K, Saitoh J, Noda SE, Harashima K, Sakurai H, Nakayama Y, Yamamoto T, Suzuki K, Nakano T, Niibe H
- Issue date: 2005 Oct 1
- Ten-year survival after High-Dose-Rate Brachytherapy combined with External Beam Radiation Therapy in high-risk prostate cancer: A comparison with the Norwegian SPCG-7 cohort.
- Authors: Wedde TB, Småstuen MC, Brabrand S, Fosså SD, Kaasa S, Tafjord G, Russnes KM, Hellebust TP, Lilleby W
- Issue date: 2019 Mar
- Normal tissue dosimetric comparison between HDR prostate implant boost and conformal external beam radiotherapy boost: potential for dose escalation.
- Authors: Hsu IC, Pickett B, Shinohara K, Krieg R, Roach M 3rd, Phillips T
- Issue date: 2000 Mar 1
- Optimal radiotherapy for prostate cancer: predictions for conventional external beam, IMRT, and brachytherapy from radiobiologic models.
- Authors: King CR, DiPetrillo TA, Wazer DE
- Issue date: 2000 Jan 1
- Comparison of the outcome and morbidity for localized or locally advanced prostate cancer treated by high-dose-rate brachytherapy plus external beam radiotherapy (EBRT) versus EBRT alone.
- Authors: Fang FM, Wang YM, Wang CJ, Huang HY, Chiang PH
- Issue date: 2008 Jul